DelveInsight

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.


Research Reports By DelveInsight

Found 2467 publications
Polycystic Kidney Disease - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 50 pages
Periodontal Disease - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 50 pages
Non-Small Cell Lung Cancer - Pipeline Insight, 2019 US$ 2,000.00 Jan, 2019 90 pages
Myelofibrosis - Epidemiology Forecast to 2028 US$ 3,250.00 Jan, 2019 50 pages
Hepatic Encephalopathy - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 50 pages
Zinplava- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Vasculitis - Epidemiology Forecast to 2028 US$ 3,250.00 Jan, 2019 50 pages
Symproic- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Pomalyst - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Natpara- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Jardiance- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Genvoya - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Actinic Keratosis- Epidemiology Forecast to 2028 US$ 3,250.00 Jan, 2019 50 pages
Zispin - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Xtandi- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Vivanza- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Trioptal - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Tekturna- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Splendil- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Rezaltas - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Prograf- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Nuvigil - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Myfortic - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Loestrin 24 Fe- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Integrilin - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Geninax - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Efient - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Cubicin- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Chronic Plaque Psoriasis - Pipeline Insight, 2019 US$ 1,500.00 Jan, 2019 70 pages
Bronchitis - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 50 pages
Autism - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 50 pages
Alimta - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
1 2 3 4 5 ... 50
Skip to top

Analytics & News by DelveInsight